Stechschulte, L. A., Ge, C., Hinds, T. D., Sanchez, E. R., Franceschi, R. T., & Lecka-Czernik, B. (2016). Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2). J Biol Chem.
Styl cytowania ChicagoStechschulte, Lance A., Chunxi Ge, Terry D. Hinds, Edwin R. Sanchez, Renny T. Franceschi, i Beata Lecka-Czernik. "Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone On Bone Through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2)." J Biol Chem 2016.
Styl cytowania MLAStechschulte, Lance A., et al. "Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone On Bone Through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2)." J Biol Chem 2016.